Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1970 2
1972 2
1973 3
1974 2
1975 1
1976 1
1977 1
1978 1
1980 2
1981 1
1982 1
1983 1
1984 2
1986 2
1987 3
1988 1
1989 4
1990 1
1991 8
1992 7
1993 10
1994 7
1995 4
1996 4
1997 2
1998 5
1999 4
2000 10
2001 2
2002 4
2003 3
2004 3
2019 1
2020 2
2021 1
2022 6
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
[Antianginal drugs].
Sawanobori T, Kugiyama K. Sawanobori T, et al. Nihon Rinsho. 2003 Apr;61 Suppl 4:654-9. Nihon Rinsho. 2003. PMID: 12735046 Review. Japanese. No abstract available.
A Stratified Analysis of the Risk Associated With Low Body Mass Index for Patients After Percutaneous Coronary Intervention.
Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Watanabe Y, Uematsu M, Makino A, Kobayashi T, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Watanabe A, Asakawa T, Sato A. Horikoshi T, et al. Among authors: sawanobori t. J Atheroscler Thromb. 2022 Jun 25. doi: 10.5551/jat.63650. Online ahead of print. J Atheroscler Thromb. 2022. PMID: 35753778 Free article.
Stratification Analysis of Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis.
Horikoshi T, Nakamura T, Yoshizaki T, Nakamura J, Makino A, Saito Y, Obata JE, Sawanobori T, Takano H, Umetani K, Watanabe A, Asakawa T, Kugiyama K. Horikoshi T, et al. Among authors: sawanobori t. J Cardiovasc Pharmacol. 2022 Feb 1;79(2):168-176. doi: 10.1097/FJC.0000000000001152. J Cardiovasc Pharmacol. 2022. PMID: 34654788
Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS-3150) and sodium-glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies.
Shikata K, Ito S, Kashihara N, Nangaku M, Wada T, Okuda Y, Sawanobori T, Sugimoto K. Shikata K, et al. Among authors: sawanobori t. J Diabetes Investig. 2022 Jul;13(7):1190-1202. doi: 10.1111/jdi.13778. Epub 2022 Apr 21. J Diabetes Investig. 2022. PMID: 35199478 Free PMC article. Clinical Trial.
117 results